Aflatoxin levels and prevalence of TP53 aflatoxin-mutations in hepatocellular carcinomas in Mexico.
Saved in:
| Title: | Aflatoxin levels and prevalence of TP53 aflatoxin-mutations in hepatocellular carcinomas in Mexico. |
|---|---|
| Authors: | Lino-Silva LS; Departamento de Patología, Instituto Nacional de Cancerología. Mexico City, Mexico.. saul.lino.sil@gmail.com., Lajous M; Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Mexico City, Mexico. / Department of Global Health and Population, Harvard T.H. Chan School of Public Health. Boston, Massachusetts, United States. mlajous@insp.mx., Brochier M; Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Mexico City, Mexico.. cisp01@insp.mx., Santiago-Ruiz L; Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Mexico City, Mexico.. luissantiago091@gmail.com., Melchor-Ruan J; Departamento de Cirugía Oncológica, Instituto Nacional de Cancerología. Mexico City, Mexico.. dr.melchor.ruan@gmail.com., Xie Y; Division of Cancer Epidemiology and Genetics, National Cancer Institute. Bethesda, Maryland, United States. yi.xie@nih.gov., Wang M; Cancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research. Gaithersburg, Maryland, United States. mingyi.wang@nih.gov., Wu D; Cancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research. Gaithersburg, Maryland, United States. dongjing.wu@nih.gov., Higson H; Cancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research. Gaithersburg, Maryland, United States. herbert.higson@nih.gov., Jones K; Cancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research. Gaithersburg, Maryland, United States. kristine.jones@nih.gov., Romero-Martínez M; Center for Research in Evaluation and Surveys, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, Mexico. martin.romero@insp.mx., Villalpando S; Center for Research in Nutrition and Health, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, México. svillalp@insp.mx., Mohar A; Unidad de Investigación Biomédica en Cáncer (Instituto de Investigaciones Biomédicas, UNAM / Dirección de Investigación, Instituto Nacional de Cancerología). Mexico City, Mexico.. alejandromohar@gmail.com., Smith JW; Department of Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University. Baltimore, United States. joshuasmith@jhu.edu., Alvarez CS; Division of Cancer Epidemiology and Genetics, National Cancer Institute. Bethesda, Maryland, United States. csalvarezp@gmail.com., McGlynn KA; Division of Cancer Epidemiology and Genetics, National Cancer Institute. Bethesda, Maryland, United States. mcglynnk@mail.nih.gov., Dean M; Division of Cancer Epidemiology and Genetics, National Cancer Institute. Bethesda, Maryland, United States. deanm@mail.nih.gov., Groopman J; Department of Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University. Baltimore, United States. jgroopm1@jhu.edu. |
| Source: | Salud publica de Mexico [Salud Publica Mex] 2022 Feb 25; Vol. 64 (1), pp. 35-40. Date of Electronic Publication: 2022 Feb 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Instituto Nacional de Salud Pública Country of Publication: Mexico NLM ID: 0404371 Publication Model: Electronic Cited Medium: Internet ISSN: 1606-7916 (Electronic) Linking ISSN: 00363634 NLM ISO Abbreviation: Salud Publica Mex Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
